GammaTile Radiation Therapy Shows Improved Brain Metastasis Control in Phase 3 Trial

New clinical data from the ROADS Phase 3 trial indicates that GammaTile radiation therapy, when combined with surgery, offers superior tumor control for newly diagnosed operable brain metastases. Patients treated with this method experienced longer recurrence-free survival compared to the standard of care. These promising findings were presented at the ASCO26 meeting.